Logo image of SAN.PA

SANOFI (SAN.PA) Stock Fundamental Analysis

Europe - Euronext Paris - EPA:SAN - FR0000120578 - Common Stock

81.61 EUR
-0.61 (-0.74%)
Last: 12/24/2025, 7:00:00 PM
Fundamental Rating

6

Taking everything into account, SAN scores 6 out of 10 in our fundamental rating. SAN was compared to 54 industry peers in the Pharmaceuticals industry. While SAN belongs to the best of the industry regarding profitability, there are some minor concerns on its financial health. SAN has a decent growth rate and is not valued too expensively. SAN also has an excellent dividend rating. These ratings would make SAN suitable for dividend investing!


Dividend Valuation Growth Profitability Health

7

1. Profitability

1.1 Basic Checks

In the past year SAN was profitable.
SAN had a positive operating cash flow in the past year.
SAN had positive earnings in each of the past 5 years.
In the past 5 years SAN always reported a positive cash flow from operatings.
SAN.PA Yearly Net Income VS EBIT VS OCF VS FCFSAN.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B 10B

1.2 Ratios

SAN's Return On Assets of 11.05% is fine compared to the rest of the industry. SAN outperforms 79.63% of its industry peers.
Looking at the Return On Equity, with a value of 19.73%, SAN is in the better half of the industry, outperforming 68.52% of the companies in the same industry.
The Return On Invested Capital of SAN (13.84%) is better than 70.37% of its industry peers.
The Average Return On Invested Capital over the past 3 years for SAN is significantly below the industry average of 13.79%.
The 3 year average ROIC (7.31%) for SAN is below the current ROIC(13.84%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 11.05%
ROE 19.73%
ROIC 13.84%
ROA(3y)5.02%
ROA(5y)6.2%
ROE(3y)8.55%
ROE(5y)10.84%
ROIC(3y)7.31%
ROIC(5y)7.07%
SAN.PA Yearly ROA, ROE, ROICSAN.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15

1.3 Margins

With an excellent Profit Margin value of 20.35%, SAN belongs to the best of the industry, outperforming 81.48% of the companies in the same industry.
In the last couple of years the Profit Margin of SAN has grown nicely.
Looking at the Operating Margin, with a value of 23.59%, SAN is in the better half of the industry, outperforming 61.11% of the companies in the same industry.
SAN's Operating Margin has improved in the last couple of years.
SAN's Gross Margin of 71.70% is in line compared to the rest of the industry. SAN outperforms 55.56% of its industry peers.
SAN's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 23.59%
PM (TTM) 20.35%
GM 71.7%
OM growth 3Y-2.73%
OM growth 5Y1.75%
PM growth 3Y-7.54%
PM growth 5Y11.4%
GM growth 3Y0.71%
GM growth 5Y0.58%
SAN.PA Yearly Profit, Operating, Gross MarginsSAN.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20 40 60

5

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so SAN is still creating some value.
SAN has about the same amout of shares outstanding than it did 1 year ago.
The number of shares outstanding for SAN remains at a similar level compared to 5 years ago.
Compared to 1 year ago, SAN has an improved debt to assets ratio.
SAN.PA Yearly Shares OutstandingSAN.PA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B
SAN.PA Yearly Total Debt VS Total AssetsSAN.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20B 40B 60B 80B 100B

2.2 Solvency

The Debt to FCF ratio of SAN is 2.21, which is a good value as it means it would take SAN, 2.21 years of fcf income to pay off all of its debts.
SAN has a better Debt to FCF ratio (2.21) than 83.33% of its industry peers.
A Debt/Equity ratio of 0.21 indicates that SAN is not too dependend on debt financing.
The Debt to Equity ratio of SAN (0.21) is better than 75.93% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.21
Debt/FCF 2.21
Altman-Z N/A
ROIC/WACC1.77
WACC7.83%
SAN.PA Yearly LT Debt VS Equity VS FCFSAN.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20B 40B 60B

2.3 Liquidity

SAN has a Current Ratio of 1.27. This is a normal value and indicates that SAN is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 1.27, SAN is in line with its industry, outperforming 42.59% of the companies in the same industry.
A Quick Ratio of 0.94 indicates that SAN may have some problems paying its short term obligations.
SAN has a Quick ratio (0.94) which is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 1.27
Quick Ratio 0.94
SAN.PA Yearly Current Assets VS Current LiabilitesSAN.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10B 20B 30B 40B

4

3. Growth

3.1 Past

SAN shows a slight negative growth in Earnings Per Share. In the last year, the EPS has decreased by -5.35%.
SAN shows a small growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 5.10% yearly.
SAN shows a small growth in Revenue. In the last year, the Revenue has grown by 2.56%.
Measured over the past years, SAN shows a small growth in Revenue. The Revenue has been growing by 3.31% on average per year.
EPS 1Y (TTM)-5.35%
EPS 3Y5.45%
EPS 5Y5.1%
EPS Q2Q%1.75%
Revenue 1Y (TTM)2.56%
Revenue growth 3Y4.17%
Revenue growth 5Y3.31%
Sales Q2Q%-7.47%

3.2 Future

SAN is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 7.11% yearly.
SAN is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 4.55% yearly.
EPS Next Y3.02%
EPS Next 2Y5.77%
EPS Next 3Y5.98%
EPS Next 5Y7.11%
Revenue Next Year0.64%
Revenue Next 2Y3.51%
Revenue Next 3Y4.42%
Revenue Next 5Y4.55%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
SAN.PA Yearly Revenue VS EstimatesSAN.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 10B 20B 30B 40B 50B
SAN.PA Yearly EPS VS EstimatesSAN.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 2 4 6 8 10

6

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 10.74, the valuation of SAN can be described as very reasonable.
SAN's Price/Earnings ratio is rather cheap when compared to the industry. SAN is cheaper than 87.04% of the companies in the same industry.
When comparing the Price/Earnings ratio of SAN to the average of the S&P500 Index (26.59), we can say SAN is valued rather cheaply.
SAN is valuated reasonably with a Price/Forward Earnings ratio of 9.50.
Based on the Price/Forward Earnings ratio, SAN is valued cheaper than 87.04% of the companies in the same industry.
SAN is valuated cheaply when we compare the Price/Forward Earnings ratio to 24.03, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 10.74
Fwd PE 9.5
SAN.PA Price Earnings VS Forward Price EarningsSAN.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, SAN is valued a bit cheaper than 68.52% of the companies in the same industry.
70.37% of the companies in the same industry are more expensive than SAN, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 19.68
EV/EBITDA 10.47
SAN.PA Per share dataSAN.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15 20 25

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates SAN does not grow enough to justify the current Price/Earnings ratio.
The decent profitability rating of SAN may justify a higher PE ratio.
PEG (NY)3.56
PEG (5Y)2.11
EPS Next 2Y5.77%
EPS Next 3Y5.98%

8

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 4.77%, SAN is a good candidate for dividend investing.
SAN's Dividend Yield is rather good when compared to the industry average which is at 1.85. SAN pays more dividend than 92.59% of the companies in the same industry.
Compared to an average S&P500 Dividend Yield of 1.88, SAN pays a better dividend.
Industry RankSector Rank
Dividend Yield 4.77%

5.2 History

The dividend of SAN has a limited annual growth rate of 4.30%.
Dividend Growth(5Y)4.3%
Div Incr Years6
Div Non Decr Years6
SAN.PA Yearly Dividends per shareSAN.PA Yearly Dividends per shareYearly Dividends per share 2019 2020 2021 2022 2023 2024 2025 1 2 3

5.3 Sustainability

SAN pays out 34.82% of its income as dividend. This is a sustainable payout ratio.
The dividend of SAN is growing, but earnings are growing more, so the dividend growth is sustainable.
DP34.82%
EPS Next 2Y5.77%
EPS Next 3Y5.98%
SAN.PA Yearly Income VS Free CF VS DividendSAN.PA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B 10B
SAN.PA Dividend Payout.SAN.PA Dividend Payout, showing the Payout Ratio.SAN.PA Dividend Payout.PayoutRetained Earnings

SANOFI

EPA:SAN (12/24/2025, 7:00:00 PM)

81.61

-0.61 (-0.74%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)10-24 2025-10-24/bmo
Earnings (Next)01-28 2026-01-28/amc
Inst Owners46.31%
Inst Owner ChangeN/A
Ins Owners0.01%
Ins Owner ChangeN/A
Market Cap198.23B
Revenue(TTM)66.91B
Net Income(TTM)13.81B
Analysts81.38
Price Target107.62 (31.87%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 4.77%
Yearly Dividend3.79
Dividend Growth(5Y)4.3%
DP34.82%
Div Incr Years6
Div Non Decr Years6
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)1.86%
Min EPS beat(2)-2.29%
Max EPS beat(2)6.02%
EPS beat(4)2
Avg EPS beat(4)4.01%
Min EPS beat(4)-2.29%
Max EPS beat(4)14.5%
EPS beat(8)4
Avg EPS beat(8)2.17%
EPS beat(12)7
Avg EPS beat(12)2.71%
EPS beat(16)11
Avg EPS beat(16)3.44%
Revenue beat(2)0
Avg Revenue beat(2)-0.96%
Min Revenue beat(2)-1.3%
Max Revenue beat(2)-0.63%
Revenue beat(4)1
Avg Revenue beat(4)-0.71%
Min Revenue beat(4)-4.57%
Max Revenue beat(4)3.66%
Revenue beat(8)2
Avg Revenue beat(8)-1.12%
Revenue beat(12)5
Avg Revenue beat(12)9.77%
Revenue beat(16)9
Avg Revenue beat(16)21.47%
PT rev (1m)1.13%
PT rev (3m)-1.94%
EPS NQ rev (1m)-0.28%
EPS NQ rev (3m)-4.14%
EPS NY rev (1m)-0.05%
EPS NY rev (3m)-0.86%
Revenue NQ rev (1m)-0.18%
Revenue NQ rev (3m)-1.69%
Revenue NY rev (1m)0.11%
Revenue NY rev (3m)0.93%
Valuation
Industry RankSector Rank
PE 10.74
Fwd PE 9.5
P/S 2.92
P/FCF 19.68
P/OCF 17.42
P/B 2.83
P/tB 21.33
EV/EBITDA 10.47
EPS(TTM)7.6
EY9.31%
EPS(NY)8.59
Fwd EY10.53%
FCF(TTM)4.15
FCFY5.08%
OCF(TTM)4.69
OCFY5.74%
SpS27.95
BVpS28.82
TBVpS3.83
PEG (NY)3.56
PEG (5Y)2.11
Graham Number70.2
Profitability
Industry RankSector Rank
ROA 11.05%
ROE 19.73%
ROCE 16.7%
ROIC 13.84%
ROICexc 16.48%
ROICexgc 66.95%
OM 23.59%
PM (TTM) 20.35%
GM 71.7%
FCFM 14.83%
ROA(3y)5.02%
ROA(5y)6.2%
ROE(3y)8.55%
ROE(5y)10.84%
ROIC(3y)7.31%
ROIC(5y)7.07%
ROICexc(3y)8.13%
ROICexc(5y)7.97%
ROICexgc(3y)35.39%
ROICexgc(5y)35.54%
ROCE(3y)8.84%
ROCE(5y)8.55%
ROICexgc growth 3Y-13.63%
ROICexgc growth 5Y-1.43%
ROICexc growth 3Y-1.55%
ROICexc growth 5Y2.05%
OM growth 3Y-2.73%
OM growth 5Y1.75%
PM growth 3Y-7.54%
PM growth 5Y11.4%
GM growth 3Y0.71%
GM growth 5Y0.58%
F-Score7
Asset Turnover0.54
Health
Industry RankSector Rank
Debt/Equity 0.21
Debt/FCF 2.21
Debt/EBITDA 0.75
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage 250
Cash Conversion 58.05%
Profit Quality 72.91%
Current Ratio 1.27
Quick Ratio 0.94
Altman-Z N/A
F-Score7
WACC7.83%
ROIC/WACC1.77
Cap/Depr(3y)73.02%
Cap/Depr(5y)67.36%
Cap/Sales(3y)6.35%
Cap/Sales(5y)5.97%
Profit Quality(3y)113.82%
Profit Quality(5y)104.22%
High Growth Momentum
Growth
EPS 1Y (TTM)-5.35%
EPS 3Y5.45%
EPS 5Y5.1%
EPS Q2Q%1.75%
EPS Next Y3.02%
EPS Next 2Y5.77%
EPS Next 3Y5.98%
EPS Next 5Y7.11%
Revenue 1Y (TTM)2.56%
Revenue growth 3Y4.17%
Revenue growth 5Y3.31%
Sales Q2Q%-7.47%
Revenue Next Year0.64%
Revenue Next 2Y3.51%
Revenue Next 3Y4.42%
Revenue Next 5Y4.55%
EBIT growth 1Y15.64%
EBIT growth 3Y1.33%
EBIT growth 5Y5.12%
EBIT Next Year29.46%
EBIT Next 3Y13.42%
EBIT Next 5Y11.66%
FCF growth 1Y24.23%
FCF growth 3Y-11.46%
FCF growth 5Y-0.14%
OCF growth 1Y10.87%
OCF growth 3Y-4.79%
OCF growth 5Y3.31%

SANOFI / SAN.PA FAQ

Can you provide the ChartMill fundamental rating for SANOFI?

ChartMill assigns a fundamental rating of 6 / 10 to SAN.PA.


What is the valuation status for SAN stock?

ChartMill assigns a valuation rating of 6 / 10 to SANOFI (SAN.PA). This can be considered as Fairly Valued.


What is the profitability of SAN stock?

SANOFI (SAN.PA) has a profitability rating of 7 / 10.


What is the expected EPS growth for SANOFI (SAN.PA) stock?

The Earnings per Share (EPS) of SANOFI (SAN.PA) is expected to grow by 3.02% in the next year.


How sustainable is the dividend of SANOFI (SAN.PA) stock?

The dividend rating of SANOFI (SAN.PA) is 8 / 10 and the dividend payout ratio is 34.82%.